Crossmark

Response to “Critical Insights on ‘Early Versus Late Initiation of Endovascular Therapy in Patients with Severe Cerebral Venous Sinus Thrombosis’ by Bücke et al.”

Crossref DOI link: https://doi.org/10.1007/s12028-024-02128-6

Published Online: 2024-09-17

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bücke, Philipp https://orcid.org/0000-0001-5204-2016
Henkes, Hans

Kaesmacher, Johannes

Hellstern, Victoria
License Information

Text and Data Mining valid from 2024-09-17

Version of Record valid from 2024-09-17
More Information

Article History

Received: 28 August 2024

Accepted: 30 August 2024

First Online: 17 September 2024

Conflicts of interest

: HH has a consultancy agreement with Phenox GmbH | Wallaby Medical and is cofounder and shareholder of CONTARA GmbH. VH has a consultant and proctoring agreement with Phenox GmbH. All other authors report no disclosures relevant to the article.

: Not applicable.

Document is current

Any future updates will be listed below